Author Question: What is the purpose of administering filgrastim (Neupogen) to a patient who is post-bowel resection ... (Read 66 times)

SAVANNAHHOOPER23 · **on:** Jul 24, 2018

What is the purpose of administering filgrastim (Neupogen) to a patient who is post-bowel resection resulting from cancer?

a. Decrease the gastrointestinal (GI) toxicity resulting from chemotherapeutic agents
b. Suppress the immune response
c. Work as an antiemetic and stimulate his appetite
d. Increase the white blood cell (WBC) counts

Question 2

Which symptom is the patient who is receiving bleomycin (Blenoxane) therapy most likely to exhibit?

a. Increased respiratory rate and cough
b. Weight gain and peripheral edema
c. Numbness and tingling of hands and feet
d. Lethargy and orthostatic hypotension

CharlieArnold · **Reply #1 on:** Jul 24, 2018

Answer to Question 1

ANS: D
Filgrastim works to stimulate WBC production and decrease the incidence of infection. Filgrastim is a colony stimulating factor, which stimulates WBC proliferation and maturation. It is particularly helpful for patients prone to neutropenia resulting from cancer therapy. Filgrastim does not affect GI toxicity, suppress immune response (it works to enhance it), or affect appetite or nausea.

Answer to Question 2

ANS: A
Compromised respiratory function may occur in patients receiving bleomycin therapy. Increased respiratory rate and cough can be signs that further problems are developing, such as heart failure. Bleomycin does not cause weight gain, peripheral edema, numbness and tingling of hands and feet, lethargy, or orthostatic hypotension.